Owing to the diverse range of uncommon functions of DGCR8 and Drosha in the cell, targeting the whole microprocessor complex via silencing all the components could better clarify the overall oncogenic or tumor-suppressive nature of this complex in the context of breast cancer. The gene discussed is DROSHA; the disease is breast carcinoma.